Sumeena Bhatia

Sumeena Bhatia is a highly experienced professional in the medical and scientific communication field, currently serving as Director of WW Medical for Thoracic Cancers at Bristol Myers Squibb since March 2018. In previous roles at Bristol Myers Squibb, Bhatia held various directorial positions related to medical communications and publications focusing on thoracic and head & neck cancers. Prior to this, Bhatia was a Director at Vaniam Group and a Scientific Director at Alligent Group. Expertise includes oncology, immunology, and disease state content development, with significant contributions to scientific publications and advisory board activities. Bhatia’s early career includes research fellowships at NIH, studying T cell costimulatory molecules, and a Research Associate position at Albert Einstein College of Medicine, where innovative microscopy techniques were developed. Bhatia earned a PhD in Immunology from the National Institute of Immunology.